Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: One route of translating the information encoded in the glycan chains of cellular glycoconjugates into physiological effects is via receptor (lectin) binding. A family of endogenous lectins, sharing folding, a distinct sequence signature and affinity for β-galactosides (thus termed galectins), does so effectively in a context-dependent manner. AREAS COVERED: An overview is given on the multifunctional nature of galectins, with emphasis on galectin-1. The broad range of functions includes vital processes such as adhesion via glycan bridging, glycoconjugate transport or triggering signaling relevant, for example, for growth regulation. Besides distinct glycoconjugates, this lectin can also interact with certain proteins so that it can target counterreceptors at all sites of location, that is, in the cytoplasm and/or nucleus, at both sides of the membrane or extracellularly. Approaches to strategically exploit galectin activities with therapeutic intentions are outlined. EXPERT OPINION: The wide versatility of sugar coding and the multifunctionality of galectin-1 explain why considering to turn the protein into a therapeutic target is an ambitious aim. Natural pathways shaped by physiologic master regulators (e.g., the tumor suppressor p16(INK4a)) are suggested to teach inspiring lessons as to how the lectin might be recruited to clinical service.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979 · cited 1×
“In order to avoid disappointment in clinical testing, due to ‘suboptimal preclinical validation’ [117] or ‘overly optimistic assumptions’ [118], the target and the setting must be chosen critically.”
BackgroundFrom lectin structure to functional glycomics: principles of the sugar code
Gabius, H.-J., André, S., Jiménez-Barbero, J., Romero, A., & Solís, D. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.01.005 · Cited by 483
Self-citationAmano, M., Eriksson, H., Manning, J. C., Detjen, K. M., André, S., Nishimura, S., Lehtiö, J., & Gabius, H. (2012) · The FEBS Journal · doi:10.1111/febs.12001 · Cited by 111 · cited 4×
“, reducing glycoprotein a2,6-sialylation by throttling sialic acid biosynthesis) and shifting the balance of galectin expression to galectin-1 (please see Figure 4 for an overview on involved reactions) [61-63].”
BackgroundSelf-citationA Half Century of Blood-Group Antigen Research. Some Personal Recollections.
Watkins, W. M. (1999) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.11.391 · Cited by 40 · cited 1×
“Whereas plant lectins (hemagglutinins), especially because of the ability of some prominent members of this superfamily to distinguish blood groups and the rich yields from easily available sources such as seeds, have a fairly long history as tools for glycophenotyping in medical research [6-8], work with endogenous (…”
Background
Cited by
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Percec, V., Leowanawat, P., Sun, H.-J., Kulikov, O., Nusbaum, C. D., Tran, T. M., Bertin, A., Wilson, D. A., Peterca, M., Zhang, S., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403323y · Cited by 310
Self-citationSolís, D., Bovin, N. V., Davis, A. P., Jiménez-Barbero, J., Romero, A., Roy, R., Smetana, K., & Gabius, H.-J. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.016 · Cited by 222
Self-citationSweet complementarity: the functional pairing of glycans with lectins
Gabius, H.-J., Manning, J. C., Kopitz, J., André, S., & Kaltner, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2163-8 · Cited by 74
“Obviously, these proteins appear to be multifunctional, and their spectrum of binding partners includes intracellular proteins [216, 217].”
BackgroundSelf-citationMurphy, P., André, S., & Gabius, H.-J. (2013) · Molecules · doi:10.3390/molecules18044026 · Cited by 54
“…for lectin blocking, such parameters will be necessary to minimize cross-reactivity among lectins of a family and also between different lectin families sharing carbohydrate specificity, a major caveat not to be neglected before claiming any application of lectin-targeted drug design [132].”
Self-citation
Metadata
- Authors
- Smetana, K., André, S., Kaltner, H., Kopitz, J., & Gabius, H.-J.
- Venue
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Published
- 2013-01-06
- Volume
- 17
- Issue
- 4
- Pages
- 379-392
- ISSN
- 1472-8222 (ISSN-L)
- 1744-7631
- OpenAlex
- W2019489405
- Cited by
- 69
- References
- 4
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target. https://app.cochat.ai/papers/10.1517/14728222.2013.750651
- The paper
- Smetana, K., André, S., Kaltner, H., Kopitz, J., & Gabius, H.-J. (2013). Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target. Expert Opinion on Therapeutic Targets. https://doi.org/10.1517/14728222.2013.750651
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.